Quanterix Corporation header image

Quanterix Corporation

QTRX

Equity

ISIN US74766Q1013 / Valor 39127916

NASDAQ (2024-09-16)
USD 12.97+1.17%

Quanterix Corporation
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Quanterix Corporation is a company focused on transforming healthcare by enhancing the precision and understanding of health to disease progression through advanced scientific research. It operates at the forefront of the healthcare industry, leveraging a combination of experienced management, leading scientists, and strategic investments to push the boundaries of precision health science. The company has established a significant global presence, serving hundreds of academic and industry clients with direct sales in North America and parts of Europe, while also reaching a wider international market through distributor partnerships. Quanterix offers a range of products and services designed to support the research needs of its customers, backed by a dedicated team of field application scientists and engineers providing comprehensive customer support worldwide. This approach underscores the company's commitment to advancing healthcare research and diagnostics through innovative technology and collaborative efforts.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-49.6%1Y
-72.8%3Y
-48.9%5Y

Performance

61.8%1Y
86.8%3Y
84.4%5Y

Volatility

Market cap

909 M

Market cap (USD)

Daily traded volume (Shares)

96,743

Daily traded volume (Shares)

1 day high/low

13.03 / 12.5

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.80%CHF 266.20
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203211
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.63%CHF 285.60
Sandoz Group Ltd
Sandoz Group Ltd Sandoz Group Ltd Valor: 124359842
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.82%CHF 34.58
Ypsomed Holding AG
Ypsomed Holding AG Ypsomed Holding AG Valor: 1939699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.17%CHF 421.50
Siegfried Holding Ltd
Siegfried Holding Ltd Siegfried Holding Ltd Valor: 1428449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.69%CHF 1,162.00
PolyPeptide Group Ltd
PolyPeptide Group Ltd PolyPeptide Group Ltd Valor: 111076085
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.27%CHF 32.25
IVF HARTMANN Holding AG
IVF HARTMANN Holding AG IVF HARTMANN Holding AG Valor: 18762425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.74%CHF 137.00
Idorsia Ltd
Idorsia Ltd Idorsia Ltd Valor: 36346343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.88%CHF 1.58
Xlife Sciences Ltd.
Xlife Sciences Ltd. Xlife Sciences Ltd. Valor: 46192960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.32%CHF 30.30
Curatis Holding Ltd
Curatis Holding Ltd Curatis Holding Ltd Valor: 133078097
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
48.89%CHF 10.75